-
Helping U.S. Patent Applicants Get Speedy Examination – Courtesy (Global IP Matters)
U.S. patent applicants often have an interest in expediting the patent examination process. The desire to speed examination can...
-
It’s not just big pharma that wants to see IPR reform in US patent legislation – By Richard Lloyd
For over an hour yesterday, as the Senate Judiciary Committee hearing on the recently introduced PATENT Act unfolded, it seemed like we were...
-
First Look At False Marking Under The AIA – Courtesy (Pharma Patents)
POSTED BY COURTENAY C. BRINCKERHOFF ON 14 MAY 2015POSTED IN FEDERAL CIRCUIT DECISIONSIn Sukumar v. Nautilus, Inc., the Federal Circuit took its first...
-
Federal Circuit Finds That FDA Citizen Petition Could Give Rise To Antitrust Liability – Courtesy (Pharma Patents)
POSTED BY COURTENAY C. BRINCKERHOFF ON 7 AUGUST 2014POSTED IN ANTITRUST;FDA;FEDERAL CIRCUIT DECISIONSIn Tyco Healthcare Group LP v. Mutual Pharmaceutical Co., Inc., the...
-
Merck scores victory in India patent battle over top diabetes meds! – Courtesy (Fierce Pharma)
In a potentially promising sign for Western drugmakers, Merck ($MRK) scored a victory in its patent battle with India’s Glenmark...
-
To Study The Scope & Importance Of Amended Patent Act On Indian Pharmaceutical Company With Respect To Innovation
1-s2-0-s2212567114002469-mainDownload
-
Telmisartan: no double-dipping says CJEU, as it avoids answering all the questions – Courtesy (The SPC Blog)
The Court of Justice of the European Union (CJEU) delivered its ruling in Case C‑577/13, Actavis Group PTC EHF, Actavis UK...
-
Suven Life’s NCEs for neurodegenerative diseases receive European & Hong Kong patents – Courtesy(Pharmabiz.com)
Suven Life Sciences Ltd (Suven), a Hyderabad-based biopharmaceutical company focussed on discovering, developing and commercialising novel pharmaceutical products, has...
